A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/17/2011	WO2011142782A2 Zone compensated multilayer laue lens and apparatus and method of fabricating the same
11/17/2011	WO2011142731A2 Formulations comprising a third generation cephalosporin and clavulanic acid
11/17/2011	WO2011142730A1 Pharmaceutical composition comprising cefixime and clavulanic acid derivative compound
11/17/2011	WO2011142724A1 Novel antimicrobial compounds and uses thereof
11/17/2011	WO2011142716A1 Novel hemifumarate salt of isoindole compound acting as bace inhibitor
11/17/2011	WO2011142677A1 Methods and compositions for the treatment of lung disorders
11/17/2011	WO2011142652A1 Composition for reducing absorption of dietary fat
11/17/2011	WO2011142621A2 Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbesartan
11/17/2011	WO2011142620A2 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants
11/17/2011	WO2011142515A1 Asymmetric liposomes for the highly efficient encapsulation of nucleic acids and hydrophilic anionic compounds, and method for preparing same
11/17/2011	WO2011142514A1 Composition containing pias3 as an active ingredient for preventing or treating cancer or immune disease
11/17/2011	WO2011142488A1 Therapeutic agent for arthritis
11/17/2011	WO2011142484A1 Therapeutic agent for viral infections comprising polyalkyleneimine
11/17/2011	WO2011142478A1 Canagliflozin containing tablets
11/17/2011	WO2011142445A1 Composition containing stabilized phosphatidylserine
11/17/2011	WO2011142381A1 Benzo- or pyrido-imidazole derivative
11/17/2011	WO2011142359A1 Spiro compound and drug for activating adiponectin receptor
11/17/2011	WO2011142316A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity
11/17/2011	WO2011142246A1 Method for inhibition of potential-dependent cation channel
11/17/2011	WO2011141921A1 Darunavir compositions
11/17/2011	WO2011141909A2 Lipoic acid and nitroxide derivatives and uses thereof
11/17/2011	WO2011141903A1 Polymorphs of alogliptin benzoate
11/17/2011	WO2011141888A1 Use of dronedarone for the preparation of a medicament for the prevention of cardiovacular hospitalizations or death or cardiovascular events in patients with permanent atrial fibrillation
11/17/2011	WO2011141872A1 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter
11/17/2011	WO2011141848A1 Morpholine compounds as mineralocorticoid receptor antagonists
11/17/2011	WO2011141847A1 An improved process for the preparation of meropenem
11/17/2011	WO2011141819A1 Improved methods for preparing squalene
11/17/2011	WO2011141791A2 Extended release formulations of desvenlafaxine base
11/17/2011	WO2011141783A2 Pharmaceutical composition comprising irbesartan
11/17/2011	WO2011141756A1 Pyrazolopyridines as inhibitors of the kinase lrrk2
11/17/2011	WO2011141729A1 Novel compounds
11/17/2011	WO2011141728A1 Spirocyclic derivatives with affinity for calcium channels
11/17/2011	WO2011141716A2 Pharmaceutical compounds
11/17/2011	WO2011141713A1 New bicyclic compounds as pi3-k and mtor inhibitors
11/17/2011	WO2011141703A1 Compositions and methods for silencing apolipoprotein b
11/17/2011	WO2011141611A1 Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics
11/17/2011	WO2011141598A1 Compound with antioxidant activity
11/17/2011	WO2011141488A2 Pharmaceutical compositions comprising hydromorphone and naloxone
11/17/2011	WO2011141483A2 Stable pharmaceutical formulations containing an antihistaminic
11/17/2011	WO2011141474A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/17/2011	WO2011141458A1 Polysubstituted benzofurans and medicinal applications thereof
11/17/2011	WO2011141456A1 Methods and compositions for the treatment of fluid accumulation in and/ or under the retina
11/17/2011	WO2011141431A1 Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof
11/17/2011	WO2011141419A1 Association of the xanthine oxidase inhibitor febuxostat and metformin and use thereof
11/17/2011	WO2011141409A1 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
11/17/2011	WO2011141396A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/17/2011	WO2011141387A1 Association of xanthine oxidase inhibitors and statins and use thereof
11/17/2011	WO2011141381A1 Association of xanthine oxidase inhibitors and calcium antagonists and use thereof
11/17/2011	WO2011141326A1 Substituted heterocyclyl benzyl pyrazoles, and use thereof
11/17/2011	WO2011141325A1 Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases
11/17/2011	WO2011141241A1 Alcohol-resistant oral pharmaceutical form
11/17/2011	WO2011141192A1 Pharmaceutical dosage form comprising one or more antiretroviral active ingredients
11/17/2011	WO2011141180A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
11/17/2011	WO2011141113A2 Combination of vitamin k and nicotinamide
11/17/2011	WO2011141004A1 Cefodizime sodium hydrate, preparation method and uses thereof
11/17/2011	WO2011140998A1 Aralkyl diamine derivatives and uses thereof as antidepressant
11/17/2011	WO2011140981A1 Use of 5'-methoxy-3',4'-methylenedioxycinnamic acid isobutylamide on preparing medicaments for anti-depression
11/17/2011	WO2011140936A1 5,5-disubstituted-2-imino-pyrrolidine derivatives, preparation methods and pharmaceutical uses thereof
11/17/2011	WO2011140872A1 Slow release tablet of elemene anti-tumor plant medicine
11/17/2011	WO2011140858A1 Aildenafil citrate crystal form o, preparation method and use thereof
11/17/2011	WO2011140832A1 Hexaketide compound and medicinal use thereof
11/17/2011	WO2011140817A1 1-[(4-hydroxypridin-4-yl) methyl] pyridine-2(1h)-one derivatives, preparation methods and uses thereof
11/17/2011	WO2011140816A1 Thienopyridine ester derivative containing nitrile, preparation method, use and composition thereof
11/17/2011	WO2011140682A1 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[(8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
11/17/2011	WO2011140681A1 Acrylamide compounds and use thereof for inhibiting apoptosis
11/17/2011	WO2011140680A1 Urea compounds and use thereof for inhibiting apoptosis
11/17/2011	WO2011140676A1 Rhizoma gastrodiae plant extract used to prevent and treat alzheimer disease and vascular dementia and mixed type diseases thereof and preparative method thereof
11/17/2011	WO2011140655A1 Phenolic compositions derived from apple skin and uses thereof
11/17/2011	WO2011140644A1 Polyacetal or polyketal and ether polymers
11/17/2011	WO2011140640A1 Selective glycosidase inhibitors and uses thereof
11/17/2011	WO2011140627A1 Nucleic acid-containing lipid particles and related methods
11/17/2011	WO2011140608A1 Neuropsychopharmacological treatment regimes for treating psychological disorders
11/17/2011	WO2011140607A1 A method of treatment and diagnosis
11/17/2011	WO2011124923A3 Pyrazolyl ureas as p38 map kinase inhibitors
11/17/2011	WO2011121250A3 Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
11/17/2011	WO2011120156A8 Polyamine-containing polymers and methods of synthesis and use
11/17/2011	WO2011119605A3 Morphinane derivatives containing a carboxamide group as opioid receptor ligands
11/17/2011	WO2011113855A3 Pharmaceutical composition for treatment of increased intraocular pressure
11/17/2011	WO2011113798A3 Inhibitors of semicarabazide - sensitive amine oxidase
11/17/2011	WO2011113507A3 Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
11/17/2011	WO2011105902A3 Antagonists of complement component 8-beta (c8-beta) and uses thereof
11/17/2011	WO2011105900A3 Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
11/17/2011	WO2011104412A3 Compounds for treating alzheimer's disease
11/17/2011	WO2011103442A3 Synthesis of the potent immunosuppressant agents dalesconol a and b
11/17/2011	WO2011095535A3 Pregnane compounds condensed in position 16,17 with a pyrolidine ring with glucocorticoid activity
11/17/2011	WO2011091319A3 Dendritic cell vaccines
11/17/2011	WO2011090885A3 Enhanced anti-microbial pdt
11/17/2011	WO2011090725A3 Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
11/17/2011	WO2011090724A3 Gastroretentive solid oral dosage forms with lipid-based low-density excipient
11/17/2011	WO2011090666A9 Methods for treating autism
11/17/2011	WO2011085209A3 Methods and compositions for applying moxifloxacin to the ear
11/17/2011	WO2011085162A3 Topical transdermal dexmedetomidine compositions and methods of use thereof
11/17/2011	WO2011085039A3 Use of histone acetyltransferase inhibitors as novel anti-cancer therapies
11/17/2011	WO2011085033A3 Dp2 antagonist and uses thereof
11/17/2011	WO2011085013A3 Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
11/17/2011	WO2011084518A3 Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
11/17/2011	WO2011084434A3 Aza-ring fused indole and indoline derivatives
11/17/2011	WO2011083999A3 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
11/17/2011	WO2011082409A3 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/17/2011	WO2011082369A3 Injectable formulations for parenteral administration

1 ... 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 ... 7860